Ligand Design and Preparation, Photophysical Properties, and Device Performance of an Encapsulated-Type Pseudo-Tris(heteroleptic) Iridium(III) Emitter.

The organic molecule 2-(1-phenyl-1-(pyridin-2-yl)ethyl)-6-(3-(1-phenyl-1-(pyridin-2-yl)ethyl)phenyl)pyridine (H3L) has been designed, prepared, and employed to synthesize the encapsulated-type pseudo-tris(heteroleptic) iridium(III) derivative Ir(κ6-fac-C,C',C″-fac-N,N',N″-L). Its formation takes place as a result of the coordination of the heterocycles to the iridium center and the ortho-CH bond activation of the phenyl groups. Dimer [Ir(µ-Cl)(η4-COD)]2 is suitable for the preparation of this compound of class [Ir(9h)] (9h = 9-electron donor hexadentate ligand), but Ir(acac)3 is a more appropriate starting material. Reactions were carried out in 1-phenylethanol. In contrast to the latter, 2-ethoxyethanol promotes the metal carbonylation, inhibiting the full coordination of H3L. Complex Ir(κ6-fac-C,C',C″-fac-N,N',N″-L) is a phosphorescent emitter upon photoexcitation, which has been employed to fabricate four yellow emitting devices with 1931 CIE (x:y) ∼ (0.52:0.48) and a maximum wavelength at 576 nm. These devices display luminous efficacies, external quantum efficiencies, and power efficacies at 600 cd m-2, which lie in the ranges 21.4-31.3 cd A-1, 7.8-11.3%, and 10.2-14.1 lm W1-, respectively, depending on the device configuration.

Two Synthetic Tools to Deepen the Understanding of the Influence of Stereochemistry on the Properties of Iridium(III) Heteroleptic Emitters.

Two complementary procedures are presented to prepare cis-pyridyl-iridium(III) emitters of the class [3b+3b+3b'] with two orthometalated ligands of the 2-phenylpyridine type (3b) and a third ligand (3b'). They allowed to obtain four emitters of this class and to compare their properties with those of the trans-pyridyl isomers. The finding starts from IrH5(PiPr3)2, which reacts with 2-(p-tolyl)pyridine to give fac-[Ir{κ2-C,N-[C6MeH3-py]}3] with an almost quantitative yield. Stirring the latter in the appropriate amount of a saturated solution of HCl in toluene results in the cis-pyridyl adduct IrCl{κ2-C,N-[C6MeH3-py]}2{κ1-Cl-[Cl-H-py-C6MeH4]} stabilized with p-tolylpyridinium chloride, which can also be transformed into dimer cis-[Ir(µ-OH){κ2-C,N-[C6MeH3-py]}2]2. Adduct IrCl{κ2-C,N-[C6MeH3-py]}2{κ1-Cl-[Cl-H-py-C6MeH4]} directly generates cis-[Ir{κ2-C,N-[C6MeH3-py]}2{κ2-C,N-[C6H4-Isoqui]}] and cis-[Ir{κ2-C,N-[C6MeH3-py]}2{κ2-C,N-[C6H4-py]}] by transmetalation from Li[2-(isoquinolin-1-yl)-C6H4] and Li[py-2-C6H4]. Dimer cis-[Ir(µ-OH){κ2-C,N-[C6MeH3-py]}2]2 is also a useful starting complex when the precursor molecule of 3b' has a fairly acidic hydrogen atom, suitable for removal by hydroxide groups. Thus, its reactions with 2-picolinic acid and acetylacetone (Hacac) lead to cis-Ir{κ2-C,N-[C6MeH3-py]}2{κ2-O,N-[OC(O)-py]} and cis-Ir{κ2-C,N-[C6MeH3-py]}2{κ2-O,O-[acac]}. The stereochemistry of the emitter does not significantly influence the emission wavelengths. On the contrary, its efficiency is highly dependent on and associated with the stability of the isomer. The more stable isomer shows a higher quantum yield and color purity.

Acetylides for the Preparation of Phosphorescent Iridium(III) Complexes: Iridaoxazoles and Their Transformation into Hydroxycarbenes and N,C(sp3),C(sp2),O-Tetradentate Ligands.

The preparation of three families of phosphorescent iridium(III) emitters, including iridaoxazole derivatives, hydroxycarbene compounds, and N,C(sp3),C(sp2),O-tetradentate containing complexes, has been performed starting from dimers cis-[Ir(µ2-η2-C≡CR){κ2-C,N-(MeC6H3-py)}2]2 (R = tBu (1a), Ph (1b)). Reactions of 1a with benzamide, acetamide, phenylacetamide, and trifluoroacetamide lead to the iridaoxazole derivatives Ir{κ2-C,O-[C(CH2tBu)NC(R)O]}{κ2-C,N-(MeC6H3-py)}2 (R = Ph (2), Me (3), CH2Ph (4), CF3 (5)) with a fac disposition of carbons and heteroatoms around the metal center. In 2-methyltetrahydrofuran and dichloromethane, water promotes the C-N rupture of the IrC-N bond of the iridaoxazole ring of 3-5 to form amidate-iridium(III)-hydroxycarbene derivatives Ir{κ1-N-[NHC(R)O]}{κ2-C,N-(MeC6H3-py)}2{═C(CH2tBu)OH} (R = Me (6), CH2Ph (7), CF3 (8)). In contrast to 1a, dimer 1b reacts with benzamide and acetamide to give Ir{κ4-N,C,C',O-[py-MeC6H3-C(CH2-C6H4)NHC(R)O]}{κ2-C,N-(MeC6H3-py)}(R = Ph (9), Me (10)), which bear a N,C(sp3),C(sp2),O-tetradentate ligand resulting from a triple coupling (an alkynyl ligand, an amide, and a coordinated aryl group) and a C-H bond activation at the metal coordination sphere. Complexes 2-4 and 6-10 are emissive upon photoexcitation, in orange (2-4), green (6-8), and yellow (9 and 10) regions, with quantum yields between low and moderate (0.01-0.50) and short lifetimes (0.2-9.0 µs).

Alkynyl Ligands as Building Blocks for the Preparation of Phosphorescent Iridium(III) Emitters: Alternative Synthetic Precursors and Procedures.

Alkynyl ligands stabilize dimers [Ir(µ-X)(3b)2]2 with a cis disposition of the heterocycles of the 3b ligands, in contrast to chloride. Thus, the complexes of this class─cis-[Ir(µ2-η2-C≡CPh){κ2-C,N-(C6H4-Isoqui)}2]2 (Isoqui = isoquinoline) and cis-[Ir(µ2-η2-C≡CR){κ2-C,N-(MeC6H3-py)}2]2 (R = Ph, tBu)─have been prepared in high yields, starting from the dihydroxo-bridged dimers trans-[Ir(µ-OH){κ2-C,N-(C6H4-Isoqui)}2]2 and trans-[Ir(µ-OH){κ2-C,N-(MeC6H3-py)}2]2 and terminal alkynes. Subsequently, the acetylide ligands have been employed as building blocks to prepare the orange and green iridium(III) phosphorescent emitters, Ir{κ2-C,N-[C(CH2Ph)Npy]}{κ2-C,N-(C6H4-Isoqui)}2 and Ir{κ2-C,N-[C(CH2R)Npy]}{κ2-C,N-(MeC6H3-py)}2 (R = Ph, tBu), respectively, with an octahedral structure of fac carbon and nitrogen atoms. The green emitter Ir{κ2-C,N-[C(CH2tBu)Npy]}{κ2-C,N-(MeC6H3-py)}2 reaches 100% of quantum yield in both the poly(methyl methacrylate) (PMMA) film and 2-MeTHF at room temperature. In organic light-emitting diode (OLED) devices, it demonstrates very saturated green emission at a peak wavelength of 500 nm, with an external quantum efficiency (EQE) of over 12% or luminous efficacy of 30.7 cd/A.

Pseudo-Tris(heteroleptic) Red Phosphorescent Iridium(III) Complexes Bearing a Dianionic C,N,C',N'-Tetradentate Ligand.

1-Phenyl-3-(1-phenyl-1-(pyridin-2-yl)ethyl)isoquinoline (H2MeL) has been prepared by Pd(N-XantPhos)-catalyzed "deprotonative cross-coupling processes" to synthesize new phosphorescent red iridium(III) emitters (601-732 nm), including the carbonyl derivative Ir(κ4-cis-C,C'-cis-N,N'-MeL)Cl(CO) and the acetylacetonate compound Ir(κ4-cis-C,C'-cis-N,N'-MeL)(acac). The tetradentate 6e-donor ligand (6tt') of these complexes is formed by two different bidentate units, namely, an orthometalated 2-phenylisoquinoline and an orthometalated 2-benzylpyridine. The link between the bidentate units reduces the number of possible stereoisomers of the structures [6tt' + 3b] (3b = bidentate 3e-donor ligand), with respect to a [3b + 3b' + 3b″] emitter containing three free bidentate units, and it permits a noticeable stereocontrol. Thus, the isomers fac-Ir(κ4-cis-C,C'-cis-N,N'-MeL){κ2-C,N-(C6H4-py)}, mer-Ir(κ4-cis-C,C'-cis-N,N'-MeL){κ2-C,N-(C6H3R-py)}, and mer-Ir(κ4-trans-C,C'-cis-N,N'-MeL){κ2-C,N-(C6HR-py)} (R = H, Me) have also been selectively obtained. The new emitters display short lifetimes (0.7-4.6 µs) and quantum yields in a doped poly(methyl methacrylate) film at 5 wt % and 2-methyltetrahydrofuran at room temperature between 0.08 and 0.58. The acetylacetonate complex Ir(κ4-cis-C,C'-cis-N,N'-MeL)(acac) has been used as a dopant for a red PhOLED device with an electroluminescence λmax of 672 nm and an external quantum efficiency of 3.4% at 10 mA/cm2.

Insertion of Unsaturated C-C Bonds into the O-H Bond of an Iridium(III)-Hydroxo Complex: Formation of Phosphorescent Emitters with an Asymmetrical ß-Diketonate Ligand.

A synthetic methodology to prepare iridium(III) emitters of the class [3b+3b+3b'] with two ortho-metalated 1-phenylisoquinolines and an asymmetrical ß-diketonate has been discovered. The abstraction of the chloride ligands of the dimer [Ir(µ-Cl){κ2-C,N-(C6H4-isoqui)}2]2 (1, C6H5-isoqui = 1-phenylisoquinoline) with AgBF4 in acetone and the subsequent addition of water to the resulting solution affords the water solvate mononuclear complex [Ir{κ2-C,N-(C6H4-isoqui)}2(H2O)2]BF4 (2), which reacts with KOH to give the dihydroxo-bridged dimer [Ir(µ-OH){κ2-C,N-(C6H4-isoqui)}2]2 (3). Treatment of the latter with dimethyl acetylenedicarboxylate leads to Ir{κ2-C,N-(C6H4-isoqui)}2{κ2-O,O-[OC(CO2CH3)CHC(OCH3)O]} (4), as a result of the anti-addition of the O-H bond of a mononuclear [Ir(OH){κ2-C,N-(C6H4-isoqui)}2] fragment to the C-C triple bond of the alkyne and the coordination of one of the carboxylate substituents to the metal center. Complex 3 also reacts with α,ß-unsaturated ketones. The reaction with 3-(4-methylphenyl)-1-phenylprop-2-en-1-one affords Ir{κ2-C,N-(C6H4-isoqui)}2{κ2-O,O-[OC(C6H5)CHC(p-C6H4Me)O]} (5), whereas methyl vinyl ketone gives a mixture of Ir{κ2-C,N-(C6H4-isoqui)}2{κ2-O,O-[OC(CH3)CHCHO]} (6) and Ir{κ2-C,N-(C6H4-isoqui)}2{κ2-O,O-[OC(CH3)CHC(CH═CH2)O]} (7). Complexes 5 and 6 are the result of the addition of the O-H bond of the mononuclear [Ir(OH){κ2-C,N-(C6H4-isoqui)}2] fragment to the C-C double bond of the α,ß-unsaturated ketones and the coordination of the carbonyl group to the iridium center, to generate O,O-chelates which lose molecular hydrogen to aromatize into the asymmetrical ß-diketonate ligands. Complexes 4-7 are phosphorescent emitters in the red spectral region (599-672 nm) in doped poly(methyl methacrylate) (PMMA) film at 5 wt % at room temperature and 2-methyltetrahydrofuran at room temperature and 77 K. They display short lifetimes (0.8-2.5 µs) and quantum yields in both doped PMMA films and in 2-methyltetrahydrofuran at room temperature depending on the substituents of the ß-diketonate: about 0.6-0.5 for 4 and 6 and ca. 0.35 for 5 and 7.

Phosphorescent Iridium(III) Complexes with a Dianionic C,C',N,N'-Tetradentate Ligand.

To prepare new phosphorescent iridium(III) emitters, 2-phenyl-6-(1-phenyl-1-(pyridin-2-yl)ethyl)pyridine (H2L) has been designed and its reactions with [Ir(µ-Cl)(η4-COD)]2 (1, COD = 1,5-cyclooctadiene) have been studied. The products obtained depend on the refluxing temperature of the solvent. Thus, complexes Ir(κ4-C,C',N,N'-L)Cl(CO) (2), [Ir(η4-COD)(κ2-N,N'-H2L)][IrCl2(η4-COD)] (3), and [Ir(µ-Cl)(κ4-C,C',N,N'-L)]2 (4) have been formed in 2-ethoxyethanol, propan-2-ol, and 1-phenylethanol, respectively. Complex 4 reacts with K(acac) to give the acetylacetonate derivative Ir(κ4-C,C',N,N'-L)(acac) (5). Complexes 2 and 5 are efficient blue-green and green emitters of classes [6tt+1m+2m] and [6tt+3b], respectively. They display lifetimes in the range of 1.1-4.5 µs and high quantum yields (0.54-0.87) in both PMMA films and 2-MeTHF at room temperature.

Preparation and Photophysical Properties of Bis(tridentate) Iridium(III) Emitters: Pincer Coordination of 2,6-Di(2-pyridyl)phenyl.

The way to prepare molecular emitters [5t + 4t'] of iridium(III) with a 5t ligand derived from the abstraction of the hydrogen atom at position 2 of the aryl group of 1,3-di(2-pyridyl)benzene (dpybH) is shown. In addition, the photophysical properties of the new emitters are compared with those of their counterparts resulting from the deprotonation of 1,3-di(2-pyridyl)-4,6-dimethylbenzene (dpyMebH), at the same position, which are also synthesized. Treatment of 0.5 equiv of the dimer [Ir(µ-Cl)(η2-COE)2]2 (COE = cyclooctene) with 1.0 equiv of Hg(dpyb)Cl leads to the iridium(III) derivative IrCl2{κ3-N,C,N-(dpyb)}(η2-COE) (3), which reacts with 2-(1H-imidazol-2-yl)-6-phenylpyridine (HNImpyC6H5) and 2-(1H-benzimidazol-2-yl)-6-phenylpyridine (HNBzimpyC6H5) in the presence of Na2CO3 to give Ir{κ3-C,N,N-(NImpyC6H4)}{κ3-N,C,N-(dpyb)} (4) and Ir{κ3-C,N,N-(NBzimpyC6H4)}{κ3-N,C,N-(dpyb)} (5), respectively. Similar reactions of the Williams's dimer [IrCl(µ-Cl){κ3-N,C,N-(dpyMeb)}]2 with HNImpyC6H5 and HNBzimpyC6H5 in the presence of Na2CO3 afford the dimethylated counterparts Ir{κ3-C,N,N-(NImpyC6H4)}{κ3-N,C,N-(dpyMeb)} (6) and Ir{κ3-C,N,N-(NBzimpyC6H4)}{κ3-N,C,N-(dpyMeb)} (7), whereas 2-(6-phenylpyridine-2-yl)-1H-indole (HIndpyC6H5) initially gives IrH{κ2-N,N-(IndpyC6H5)}{κ3-N,C,N-(dpyMeb)} (8) and subsequently Ir{κ3-C,N,N-(IndpyC6H4)}{κ3-N,C,N-(dpyMeb)} (9). Complexes 4-7 are phosphorescent green emitters (λem 490-550 nm), whereas 9 is greenish yellow emissive (λem 547-624 nm). They display lifetimes in the range 0.5-9.7 µs and quantum yields in both doped poly(methyl)methacrylate films and in 2-methyltetrahydrofuran at room temperature depending upon the ligands: 0.5-0.7 for 6 and 7, about 0.4 for 4 and 5, and 0.3-0.2 for 9.

Preparation of Phosphorescent Iridium(III) Complexes with a Dianionic C,C,C,C-Tetradentate Ligand.

The preparation and photophysical properties of heteroleptic iridium(III) complexes containing a dianionic C,C,C,C-tetradentate ligand and a cyclometalated phenylpyridine group are described. Complex [Ir(µ-OMe)(COD)]2 (1, COD = 1,5-cyclooctadiene) reacts with 1,1-diphenyl-3,3-butylenediimidazolium iodide ([PhIm(CH2)4ImPh]I2), in the presence NaOtBu, to give [Ir(µ-I){κ4- C, C, C, C-[C6H4Im(CH2)4ImC6H4]}]2 (2), which leads to {[Ir{κ4- C, C, C, C-[C6H4Im(CH2)4ImC6H4]}]2(µ-OH)(µ-OMe)} (3) by treatment first with silver trifluoromethanesulfonate (AgOTf) in acetone-dichloromethane and subsequently with KOH in methanol. The reaction of 2 with AgOTf and acetonitrile affords the bis(solvento) complex [Ir{κ4- C, C, C, C-[C6H4Im(CH2)4ImC6H4]}(CH3CN)2]OTf (4). The latter promotes the pyridyl-supported heterolytic ortho-CH bond activation of the phenyl group of 2-phenylpyridine, 2-(2,4-difluorophenyl)pyridine, 2-( p-tolyl)pyridine, and 5-methyl-2-phenylpyridine to yield Ir{κ4- C, C, C, C-[C6H4Im(CH2)4ImC6H4]}{κ2- C, N-[Ar-py]} (Ar-py = C6H4-py (5), C6H2F2-py (6), C6H3Me-py (7), C6H4-Mepy (8)) using (piperidinomethyl)polystyrene as an external base. Complexes 5-8 are blue-green emitters, which display short lifetimes (0.6-4.8 µs) and quantum yields close to unity in both doped poly(methyl methacrylate) films at 5 wt % and in 2-methyltetrahydrofuran at room temperature.

Preparation of Tris-Heteroleptic Iridium(III) Complexes Containing a Cyclometalated Aryl-N-Heterocyclic Carbene Ligand.

A new class of phosphorescent tris-heteroleptic iridium(III) complexes has been discovered. The addition of PhMeImAgI (PhMeIm = 1-phenyl-3-methylimidazolylidene) to the dimer [Ir(µ-Cl)(COD)]2 (1; COD = 1,5-cyclooctadiene) affords IrCl(COD)(PhMeIm) (2), which reacts with 1-phenylisoquinoline, 2-phenylpyridine, and 2-(2,4-difluorophenyl)pyridine to give the respective dimers [Ir(µ-Cl){κ2- C, C-(C6H4-ImMe)}{κ2- C, N-(C6H4-isoqui)}]2 (3), [Ir(µ-Cl){κ2- C, C-(C6H4-ImMe)}{κ2- C, N-(C6H4-py)}]2 (4), and [Ir(µ-Cl){κ2- C, C-(C6H4-ImMe)}{κ2- C, N-(C6F2H2-py)}]2 (5), as a result of the N-heterocyclic carbene (NHC)- and N-heterocycle-supported o-CH bond activation of the aryl substituents and the hydrogenation of a C-C double bond of the coordinated diene. In solution, these dimers exist as a mixture of isomers a (Im trans to N) and b (Im trans to Cl), which lie in a dynamic equilibrium. The treatment of 3-5 with Kacac (acac = acetylacetonate) yields isomers a (Im trans to N) and b (Im trans to O) of Ir{κ2- C, C-(C6H4-ImMe)}{κ2- C, N-(C6H4-isoqui)}(κ2- O, O-acac) (6a and 6b), Ir{κ2- C, C-(C6H4-ImMe)}{κ2- C, N-(C6H4-py)}(κ2- O, O-acac) (7a and 7b), and Ir{κ2- C, C-(C6H4-ImMe)}{κ2- C, N-(C6F2H4-py)}(κ2- O, O-acac) (8a and 8b), which were separated by column chromatography. The treatment of 6a with HX in acetone-water produces the protonation of the acac ligand and the formation of the bis(aquo) complex [Ir{κ2- C, C-(C6H4-ImMe)}{κ2- C, N-(C6H4-isoqui)}(H2O)2]X [X = BF4 (9a[BF4]), OTf (9a[OTf])]. The salt 9a[BF4] reacts with 2-(2-pinacolborylphenyl)-5-methylpyridine in the presence of 40 equiv of K3PO4 to afford Ir{κ2- C, C-(C6H4-ImMe)}{κ2- C, N-(C6H4-isoqui)}{κ2- C, N-(C6H4-Mepy)} (10a). Complexes 6a, 6b, 7a, 7b, 8a, 8b, and 10a are phosphorescent emitters (λem = 465-655 nm), which display short lifetimes in the range of 0.2-5.6 µs. They show high quantum yields both in doped poly(methyl methacrylate) films (0.34-0.87) and in 2-methyltetrahydrofuran at room temperature (0.40-0.93). From the point of view of their applicability to the fabrication of organic-light-emitting-diode devices, a notable improvement with regard to those containing two cyclometalated C,N ligands is achieved. The introduction of the cyclometalated aryl-NHC group allows one to reach a brightness of 1000 cd/m2 at a lower voltage and appears to give rise to higher luminous efficacy and power efficacy.

η1 -Arene Complexes as Intermediates in the Preparation of Molecular Phosphorescent Iridium(III) Complexes.

Molecular phosphorescent heteroleptic bis-tridentate iridium(III) emitters have been prepared via η1 -arene intermediates. In the presence of 4.0 mol of AgOTf, the complex [(IrCl{κ3 -N,C,N-(pyC6 HMe2 py)})(µ-Cl)]2 (1; pyC6 H2 Me2 py=1,3-di(2-pyridyl)-4,6-dimethylbenzene) reacted with 9-(6-phenylpyridin-2-yl)-9H-carbazole (PhpyCzH) and 2-phenoxy-6-phenylpyridine (PhpyOPh) to give [Ir{κ3 -N,C,N-(pyC6 HMe2 py)}{κ3 -C,N,C'-(C6 H4 pyCzH)}]OTf (2) and [Ir{κ3 -N,C,N-(pyC6 HMe2 py)}{κ3 -C,N,C'-(C6 H4 pyOPh)}]OTf (3). The X-ray diffraction structures of 2 and 3 reveal that the carbazolyl and phenoxy substituents of the C,N,C' ligand coordinate to the metal center to form an η1 -arene π bond. Treatment of 2 and 3 with KOtBu led to the deprotonation of the coordinated carbon atom of the η1 -arene group to afford the molecular phosphorescent [5t+4t'] heteroleptic iridium(III) complexes [Ir{κ3 -N,C,N-(pyC6 HMe2 py)}{κ3 -C,N,C'-(C6 H4 pyCz)}] (4) and [Ir{κ3 -N,C,N-(pyC6 HMe2 py)}{κ3 -C,N,C'-(C6 H4 pyOC6 H4 )}] (5). These complexes are green emitters that display short lifetimes and high quantum yields of 0.73 (4) and 0.87 (5) in the solid state.

A Capped Octahedral MHC6 Compound of a Platinum Group Metal.

A MHC6 complex of a platinum group metal with a capped octahedral arrangement of donor atoms around the metal center has been characterized. This osmium compound OsH{κ(2) -C,C-(PhBIm-C6 H4 )}3 , which reacts with HBF4 to afford the 14 e(-) species [Os{κ(2) -C,C-(PhBIm-C6 H4 )}(Ph2 BIm)2 ]BF4 stabilized by two agostic interactions, has been obtained by reaction of OsH6 (PiPr3 )2 with N,N'-diphenylbenzimidazolium chloride ([Ph2 BImH]Cl) in the presence of NEt3 . Its formation takes place through the C,C,C-pincer compound OsH2 {κ(3) -C,C,C-(C6 H4 -BIm-C6 H4 )}(PiPr3 )2 , the dihydrogen derivative OsCl{κ(2) -C,C-(PhBIm-C6 H4 )}(η(2) -H2 )(PiPr3 )2 , and the five-coordinate osmium(II) species OsCl{κ(2) -C,C-(PhBIm-C6 H4 )}(PiPr3 )2 .

The search for gamma-secretase and development of inhibitors.

A considerable body of evidence has accumulated in recent years implicating the beta-amyloid protein (Abeta) in the etiology of Alzheimer s disease (AD). The highly hydrophobic Abeta can nucleate and form neurotoxic fibrils that are the principal components of the cerebral plaques characteristic of AD. Abeta is formed from the amyloid-beta precursor protein (APP) through two protease activities. First, beta-secretase cleaves APP at the Abeta N-terminus, resulting in a soluble, secreted APP derivative (beta-APPs) and a 12 kDa membrane-retained C-terminal fragment. The latter is further processed to Abeta by gamma secretases, which cleave within the single transmembrane region. Other APP molecules can be cleaved by alpha-secretase within the Abeta region, thus precluding Abeta formation. Both beta- and gamma- secretase have become prime targets for the development of therapeutic agent that reduce Abeta production. Beta-secretase has recently been identified as a new membrane-anchored aspartyl protease in the cathepsin D family. Inhibitor profiling, site-directed mutagenesis, and affinity labeling together have suggested that the multi-pass presenilins are gamma-secretases, novel intramembrane-cleaving aspartyl proteases activated through autoproteolysis. In this article, we review the current knowledge of gamma-secretase biochemistry and cell biology and the development of inhibitors of this important therapeutic target.

Synthesis of purine- and pyrimidine-substituted heptadienes. The stereochemistry of cyclization and cyclopolymerization products.

A series of 1,6-heptadienes, substituted in the 4 position with nucleic acid bases 1-6, have been synthesized via Mitsunobu condensations. Guanine, adenine, thymine, and uracil derivatives can be prepared directly by coupling the protected base with 1,6-heptadien-4-ol (7). However, coupling protected cytosine and 7 gives an O-alkylated product. Thus, the cytosine derivative must be prepared from the uracil-substituted heptadienes via the triazole. The free-radical addition of CCl(4) and BrCCl(3) to these adducts was investigated. In all cases, both 1:1 and 1:2 adducts were obtained. The 1:1 adduct was identified as the cyclized product of the initially formed 5-hexen-1-yl radical. The cyclization takes place in a stereospecific manner, with only one of the four possible diastereomers resulting. NMR studies indicate that all substituents are cis in this product. In the case of the addition of CCl(4) to the uracil-substituted heptadiene, this conclusion was confirmed by an X-ray structure determination of the isolated cyclized product. The free-radical-initiated cyclocopolymerizations of 1-6 with SO(2) gave 1:1 copolymers with cis-linked five-membered rings. Two-dimensional NMR studies on poly(2-SO(2)) showed predominately the cis-syn isomer while poly(6-SO(2)) has an approximately equal amount of cis-syn and cis-anti isomers.

Designed helical peptides inhibit an intramembrane protease.

gamma-Secretase cleaves the transmembrane domain of the amyloid precursor protein, a process implicated in the pathogenesis of Alzheimer's disease, and this enzyme is a founding member of an emerging class of intramembrane proteases. Modeling and mutagenesis suggest a helical conformation for the substrate transmembrane domain upon initial interaction with the protease. Moreover, biochemical evidence supports the presence of an initial docking site for substrate on gamma-secretase that is distinct from the active site, a property predicted to be generally true of intramembrane proteases. Here we show that short peptides designed to adopt a helical conformation in solution are inhibitors of gamma-secretase in both cells and enzyme preparations. Helical peptides with all d-amino acids are the most potent inhibitors and represent potential therapeutic leads. Subtle modifications that disrupt helicity also substantially reduce potency, suggesting that this conformation is critical for effective inhibition. Fluorescence lifetime imaging in intact cells demonstrates that helical peptides disrupt binding between substrate and protease, whereas an active site-directed inhibitor does not. These findings are consistent with helical peptides interacting with the initial substrate docking site of gamma-secretase, suggesting a general strategy for the development of potent and specific inhibitors of intramembrane proteases.